• Cefiderocol Efficacy Against Resistant Enterobacterales in E

  2026-05-11

  This study systematically evaluated the in vitro activity of cefiderocol against a diverse collection of European Enterobacterales, including isolates resistant to meropenem and modern β-lactam/β-lactamase inhibitor combinations. The findings reveal cefiderocol's superior or comparable efficacy, offering critical guidance for antimicrobial stewardship and resistance management.

• Omeprazole (A2845): Protocol & QC Guidance for Research Use

  2026-05-10

  Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor for research on gastric acid secretion and antiulcer drug development. This product is not intended for diagnostic or clinical use, and care must be taken to follow solubility and storage guidelines to ensure data reliability.

• Thapsigargin: SERCA Pump Inhibitor for Calcium Pathway Resea

  2026-05-09

  Thapsigargin from APExBIO is the benchmark SERCA pump inhibitor, unlocking high-precision dissection of calcium signaling and endoplasmic reticulum stress in both cellular and animal models. This guide delivers actionable protocols, advanced use-cases, and troubleshooting strategies to maximize reproducibility and insight in apoptosis and neurodegenerative disease studies.

• RNA Pol II Inhibition Triggers Apoptosis via Pol IIA Loss, N

  2026-05-09

  Harper et al. (2025) illuminate a new paradigm: cell death following RNA polymerase II inhibition is not due to passive mRNA loss but is actively signaled by the depletion of hypophosphorylated RNA Pol IIA, initiating apoptosis. Their mechanistic insight redefines our understanding of transcriptional inhibition lethality and suggests new avenues for targeting apoptotic pathways in cancer research.

• Polyanion-Engineered RNA Nanoparticles: Structure and Functi

  2026-05-08

  This article reviews how chemically tailored polyanions modulate the structure, stability, and delivery efficiency of ternary RNA nanoparticles, as demonstrated in the recent ACS Nano study by Hu et al. The study systematically deciphers how polyanion hydrophobicity and PEG architecture balance extracellular stability and intracellular unpackaging, revealing new avenues for rational design of RNA nanocarriers.

• Simvastatin (Zocor): Applied Workflows in Cancer & Lipid Res

  2026-05-07

  Simvastatin (Zocor) from APExBIO serves as a trusted tool for both cholesterol and cancer research, enabling robust workflows from apoptosis induction in hepatic cancer cells to advanced autophagy assays in prostate models. This guide delivers validated protocol enhancements, troubleshooting strategies, and translatable insights for maximizing experimental rigor and data reproducibility.

• AR Heterogeneity Shapes Prostate Cancer Therapy Response

  2026-05-07

  This study delineates how androgen receptor (AR) expression heterogeneity in prostate cancer cells underlies distinct biological behaviors and responses to castration and enzalutamide therapies. By linking AR status to therapeutic resistance and identifying BCL-2 as a potential target, the research advances precision strategies for treatment-resistant prostate cancers.

• Epoxomicin: Precision Proteasome Inhibitor for Pathway Resea

  2026-05-06

  Epoxomicin empowers researchers to dissect the ubiquitin-proteasome pathway with nanomolar specificity, enabling advanced protein degradation assays and disease modeling. This guide delivers actionable workflows, troubleshooting insights, and data-backed advantages for maximizing experimental impact with Epoxomicin from APExBIO.

• UBC9-Mediated PINK1 SUMOylation Modulates Mitophagy in PD Mo

  2026-05-06

  This study identifies UBC9 as a regulator of PINK1 SUMOylation, promoting mitophagy and reducing oxidative stress in Parkinson’s disease models. By elucidating the SUMOylation sites on PINK1 and demonstrating functional outcomes in both cellular and animal models, the work suggests UBC9 as a potential target for modifying PD progression.

• N3-kethoxal: Precision Probe for RNA Structure and Genome Ma

  2026-05-05

  N3-kethoxal (3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one) enables high-resolution mapping of RNA and accessible DNA regions, integrating seamlessly with bioorthogonal click chemistry workflows. By building on innovations like KAS-ATAC sequencing, it delivers reproducible, quantitative insights into nucleic acid dynamics for both in vitro and in vivo studies.

• Tofacitinib (CP-690550): Redefining Macrophage Modulation in

  2026-05-05

  Explore how Tofacitinib (CP-690550) uniquely restores mitochondrial function and regulates inflammatory macrophages in rheumatoid arthritis. This article dissects recent breakthroughs and guides advanced immune cell assay design.

• Nystatin (Fungicidin): Optimizing Antifungal Workflows in Re

  2026-05-04

  Nystatin (Fungicidin) stands out as a polyene antifungal with robust, quantifiable activity against diverse Candida and Aspergillus models. This article details how precise protocol parameters, troubleshooting strategies, and insights from recent infection studies can empower researchers to maximize data reliability and address antifungal resistance challenges.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-05-04

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides sensitive, specific fluorescence detection of goat primary antibodies in immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA. It is not suitable for detection of primary antibodies from non-goat species or for applications outside validated immunodetection workflows.

• MLN2238 and CREB: Linking Proteasome β5 Inhibition to Proteo

  2026-05-03

  Explore how MLN2238, a potent proteasome β5 subunit inhibitor, unveils new frontiers in protein homeostasis research by modulating CREB signaling pathways. Discover actionable insights that go beyond oncology to inform advanced assay design.

• UBC9-Mediated PINK1 SUMOylation Regulates Mitophagy in Parki

  2026-05-02

  This study reveals that UBC9 enhances mitophagy and attenuates oxidative stress in Parkinson’s disease models by promoting SUMOylation of PINK1. The findings provide mechanistic insight into mitochondrial quality control and highlight potential molecular targets for disease intervention.

407 records 9/28 page Previous Next First page 上5页 678910 下5页 Last page